UTHR — UNITED THERAPEUTICS Corp
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1082554 ·
Last close
$584.10
Market Cap
$24.88B
52W High
$614.23
52W Low
$455.63
ADV30
596,185
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 832,500,000 | 733,400,000 | 241,300,000 | 258,600,000 | 7,034,100,000 | 1,188,900,000 | 758,100,000 |
| Jun 2026 | 783,300,000 | 683,800,000 | 330,800,000 | 333,000,000 | 7,220,100,000 | 1,803,200,000 | 819,800,000 |
| Mar 2026 | 781,500,000 | 648,100,000 | 325,800,000 | 274,900,000 | 6,714,200,000 | 1,279,700,000 | 813,100,000 |
| Dec 2025 | 790,200,000 | 686,800,000 | 357,500,000 | 364,300,000 | 7,880,000,000 | 1,557,100,000 | 783,800,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,429,600,000
Investing CF
$93,000,000
Financing CF
$-1,673,800,000
CapEx
$-562,400,000
Dividends Paid
—
Buybacks
$-2,055,200,000
EPS Diluted TTM
$26.50
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$9,423,400,000
Inventory
$201,900,000
Receivables
$348,600,000
ST Investments
$879,000,000
EBIT TTM
$1,519,700,000
Pretax Income TTM
$1,507,800,000
Interest Exp TTM
$11,900,000
Analysts
14
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,187,500,032
EBITDA
$1,351,299,968
Free Cash Flow
$454,624,992
Enterprise Value
$21,867,814,912
Total Cash
$2,067,900,032
Total Debt
$0
Shares Out
42,588,726
Trailing EPS
$26.49
Book Value
$148.08
ROE
19.1%
ROA
10.9%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,182,700,000 | 1,517,200,000 | 1,334,700,000 | 7,880,000,000 | 783,800,000 | 7,096,200,000 | 1,561,200,000 |
| Dec 2024 | 2,877,400,000 | 1,448,100,000 | 1,195,100,000 | 7,364,000,000 | 920,000,000 | 6,444,000,000 | 1,327,100,000 |
| Dec 2023 | 2,327,500,000 | 1,184,900,000 | 984,800,000 | 7,167,000,000 | 1,182,200,000 | 5,984,800,000 | 978,000,000 |
| Dec 2022 | 1,936,300,000 | 979,700,000 | 727,300,000 | 6,044,500,000 | 1,247,800,000 | 4,796,700,000 | 802,500,000 |
TTM Snapshot
Revenues TTM
$3,154,500,000
NetIncome TTM
$1,310,900,000
OpCashFlow TTM
—
Assets (Latest)
$7,220,100,000
Forward EPS
$33.89
Max Pain — expiry 2027-01-15
max pain strike: $560.00 · spot: $577.34 · call oi: 1,857 · put oi: 608
Expected Move to 2027-01-15:
±$55.75
(9.66%) —
implied range
$521.59 –
$633.09
· ATM straddle on $580.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VTRS | Viatris Inc | $23.45B | $20.45 | — |
| INSM | INSMED Inc | $26.73B | $121.86 | — |
| ROIV | Roivant Sciences Ltd. | $28.05B | $38.71 | — |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | $20.96B | $156.50 | — |
| RPRX | Royalty Pharma plc | $30.58B | $68.68 | — |
News headlines (Yahoo Finance, 1h cache)
United Therapeutics Prepares for TYVASO Expansion After $833 Million Quarter
2026-11-17 03:12 · Yahoo
SGIOY or UTHR: Which Is the Better Value Stock Right Now?
2026-11-16 15:40 · Yahoo
What iShares S&P Mid-Cap 400 Growth ETF (IJK) Bought: FTI Leads on Tuesday
2026-11-12 11:05 · Yahoo
iShares Core S&P Mid-Cap (IJH) Adds TechnipFMC and United Therapeutics on Tuesday
2026-11-12 11:04 · Yahoo
United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences
2026-11-09 12:00 · Yahoo
The 5 most interesting analyst questions from United Therapeutics’s Q3 2026 earnings call
2026-11-08 22:37 · Yahoo
SPDR S&P MidCap 400 ETF (MDY) Adds Glaukos and United Therapeutics on Wednesday
2026-11-06 11:04 · Yahoo
United Therapeutics (UTHR) Stock May Be Undervalued After $2B Buyback Plan
2026-11-05 17:13 · Yahoo
MannKind Sees Q4 Profit and Record Revenue as Drug Launches Gain Traction
2026-11-18 12:13 · Yahoo
iShares Core S&P Mid-Cap (IJH) Sells ATI and TechnipFMC on Nov. 12
2026-11-16 11:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.